Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-049683)

Filing Details

Accession Number:: 0001209191-19-049683
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-16 17:28:24
Reporting Period:: 2019-09-13

Accepted Time:: 2019-09-16 17:28:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1642380	Oncocyte Corp	OCX	In Vitro & In Vivo Diagnostic Substances (2835)	271041563

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1786237	T Tony Kalajian	1010 Atlantic Avenue, Suite 102 Alameda CA 94501	Svp-Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2019-09-13	10,000	$1.98	10,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price of $1.98 per share represents a weighted average of prices ranging from $1.94 to $1.987 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.